How Much Will Ophthalmology Medicare Payments Drop in 2027?
As of October 2026, the proposed 2027 Medicare Physician Fee Schedule includes an estimated 3% to 4% overall reduction in ophthalmology allowed charges, driven by a lower conversion factor and the expiration of the temporary 2.5% payment increase enacted for 2026. The American Academy of Ophthalmology confirmed these figures at AAO 2026 in New Orleans (October 9 to 12) and has stated that the final rule is expected in early November 2026, with changes taking effect January 1, 2027.
Cataract surgery takes a direct hit. The proposed payment for CPT 66984 drops to approximately $444.34, a roughly 4% reduction from 2026 levels.
Modifier 25 faces a 50% same-day reduction. When a same-day E/M visit is billed alongside a procedure by the same group, the lower-valued service would be reimbursed at 50% instead of 100%.
Ophthalmology is disproportionately affected. The specialty uses modifier 25 billing more than almost any other, making the same-day E/M reduction a revenue hit that goes beyond the headline cut.
What CMS Has Proposed for 2027
CMS released the proposed 2027 Medicare Physician Fee Schedule on July 14, 2026. The public comment period closed on September 14, 2026, with more than 44,000 comments submitted. The final rule is expected around November 1, 2026, with most changes taking effect January 1, 2027.
The proposed rule affects ophthalmology in several specific ways. First, the conversion factor drops. CMS proposed a non-qualifying conversion factor of $32.84 and a qualifying APM conversion factor of $33.17, both driven primarily by the expiration of the one-year 2.5% payment increase that Congress enacted for 2026. Second, the proposed rule targets same-day evaluation and management visits billed alongside procedures with 0-day, 10-day, or 90-day global periods. Under the proposal, the higher-valued service is reimbursed at 100%, while the lower-valued same-day E/M service would be reimbursed at only 50%.
For ophthalmology, this second change is the most damaging. Intravitreal injections (CPT 67028) carry a 0-day global period, meaning an office visit billed on the same day as an injection would see a 50% payment reduction. The American Society of Retina Specialists (ASRS) called this proposal “a major reduction in reimbursement” at their annual meeting. ASCRS analysis showed the proposed payment for routine cataract surgery (CPT 66984) at $444.34, approximately 4% below 2026 levels, while ASC facility payments face a 3.3% reduction.
Does the Modifier 25 Cut Apply to My Practice?
If your ophthalmology practice bills an office visit on the same day as a procedure, injection, or diagnostic test, the modifier 25 reduction applies to your revenue. This is not a narrow edge case. It is the standard billing pattern for the majority of ophthalmology encounters.
Retina practices that perform intravitreal injections and bill a same-day E/M visit with modifier 25 are the most exposed. A practice performing 50 injections per week with a same-day E/M could lose thousands of dollars monthly under the proposed 50% reduction. Cataract surgeons billing same-day E/M visits alongside procedures with 0-day or 90-day global periods face the same reduction. General ophthalmology practices that perform diagnostic imaging such as OCT retinal imaging (CPT 92134) on the same day as a comprehensive exam are also affected, depending on payer-specific billing rules.
The AAO has stated publicly that ophthalmology uses modifier 25 more than almost any other specialty. That means the revenue exposure from this single proposed change is larger for eye care than for most of medicine.
| Proposed Change | 2026 (Current) | 2027 (Proposed) | Impact |
|---|---|---|---|
| Overall ophthalmology | Baseline (includes 2.5% temp boost) | 3% to 4% reduction | Revenue reduction across all services |
| Cataract surgery (66984) | ~$463 (2026 rate) | $444.34 proposed | ~4% cut per procedure |
| Modifier 25 same-day E/M | 100% of lower-valued service | 50% of lower-valued service | Direct 50% reduction on same-day visits |
| ASC facility payments | 2026 rates | 3.3% reduction | Lower facility payments for ASC procedures |
| Conversion factor | Includes 2.5% temporary increase | $32.84 (non-APM); $33.17 (APM) | Temp boost expires; base rate drops |
What Should Ophthalmology Practices Do Before January 1?
The final rule has not been published yet, but the direction is clear enough that practices should begin preparing now. Waiting until November or December creates a scramble that leads to missed revenue in Q1 2027. These are the steps that protect your practice regardless of how the final numbers land.
1. Audit your modifier 25 claims from the last 90 days. Pull every claim where a same-day E/M was billed alongside a procedure and calculate what the revenue impact would be at a 50% reduction. This gives you a real dollar figure, not a percentage.
2. Tighten modifier 25 documentation. Every same-day E/M must document a separately identifiable evaluation and management service. The note must show a distinct chief complaint, distinct history, distinct exam findings, and distinct medical decision-making. If the E/M note reads like a pre-procedure check, payers will deny it even without the proposed payment reduction.
3. Model the cataract surgery impact. If your practice performs 200 or more cataract cases per year, a 4% reduction on CPT 66984 compounds quickly. Run the math against your actual volume and payer mix.
4. Review ASC versus office-based procedure economics. CMS has been shifting the payment differential between office and facility settings. For some procedures, performing the service in the office setting may now yield a higher net payment than performing it in an ASC.
5. Verify your diagnosis coding is current. Claims denied for coding errors compound the revenue loss from lower payment rates. Make sure your templates reflect the FY 2027 ICD-10-CM code updates that took effect October 1, 2026.
6. Evaluate whether your billing team has the ophthalmology-specific expertise to handle these changes. General billing companies may not catch the modifier 25 documentation gaps or the payer-specific frequency limits that drive ophthalmology denials.
Across the billing companies we vet, the practices that weather fee schedule cuts best are the ones whose billing partner catches documentation gaps before the claim goes out, not after the denial comes back. If your current billing process is not built for these 2027 changes, we can connect you with a vetted ophthalmology billing company that is already preparing for the new fee schedule.
Common Billing Mistakes Heading into 2027
One question we hear constantly from practice managers is whether they can simply stop billing the same-day E/M to avoid the modifier 25 reduction. The answer is no, not without losing legitimate revenue. If the E/M service was medically necessary and separately identifiable, it should be billed. The solution is better documentation, not fewer claims.
Another mistake is treating the proposed numbers as final. The comment period drew more than 44,000 responses, and CMS may adjust the modifier 25 provision or phase it in. Practices that restructure their entire billing workflow around proposed numbers risk overreacting. The correct approach is to prepare the documentation and the process, not to change clinical patterns based on a proposal.
Providers often come to us after discovering that their billing company did not update fee schedules on January 1. In ophthalmology, where the coding is dense with bilateral rules, global period modifiers, and payer-specific frequency limits, a missed fee schedule update means every claim goes out at the wrong rate. That error compounds across hundreds of claims before anyone catches it.
In-House Billing vs. Specialized Partner
The 2027 changes raise a specific question: does your billing team have the ophthalmology expertise to manage the transition? In-house billing staff at smaller practices often handle coding for multiple specialties or rely on general billing knowledge. That approach becomes expensive when the rules shift in ways that are specific to ophthalmology.
In our experience matching providers with billing partners, the practices that see the fastest financial improvement are the ones that move from a generalist billing approach to a team that knows ophthalmology modifier rules, LCD guidelines for imaging codes, and the payer-specific documentation requirements that differ between Medicare fee-for-service and Medicare Advantage. The billing companies in our network hold certifications from AHIMA, AAPC, MGMA, the AOA, and the AAO, and they maintain an average Google rating above 4.7 across the network.
A specialized billing partner does not just file claims. They model fee schedule changes against your actual volume, audit modifier usage before submission, track payer policy differences across your specific contracts, and flag revenue risks before they hit your accounts receivable. That level of ophthalmology-specific oversight is what separates a practice that absorbs a 3% to 4% cut from one that offsets it through cleaner billing and faster collections.
Frequently Asked Questions
Not yet as of October 2026. The proposed rule was released July 14, 2026, and the comment period closed September 14. CMS is expected to publish the final rule around November 1, 2026. The final numbers may differ from the proposal, but the direction toward lower ophthalmology payments is consistent with a multi-year trend the AAO has tracked.
Intravitreal injections (CPT 67028) carry a 0-day global period. Under the proposed rule, a same-day E/M visit billed alongside the injection would be reimbursed at only 50% of its scheduled amount. For retina practices that perform dozens of injections per week, this represents a significant revenue reduction on visits that are currently billed at full value.
The proposed payment for routine cataract extraction with IOL (CPT 66984) is approximately $444.34, which represents a roughly 4% reduction from 2026 levels. ASC facility payments for cataract surgery face a separate 3.3% reduction. The combined effect is lower revenue per case for practices performing cataract surgery in either setting.
The American Academy of Ophthalmology has publicly opposed the proposed cuts and submitted formal comments to CMS during the comment period. The AAO is also advocating for Congressional action to prevent the expiration of the 2.5% temporary payment increase and to address what it calls a 33% inflation-adjusted cut to Medicare physician payment since 2001.
Do not wait. The documentation improvements needed for modifier 25 compliance are best practices regardless of whether the final rule changes the payment percentage. Audit your current modifier 25 usage, tighten your documentation, and model the financial impact now. If the final rule softens the reduction, you still benefit from cleaner claims and fewer denials.
A specialized ophthalmology billing partner models fee schedule changes against your actual procedure volume and payer mix, audits modifier 25 documentation before claims are submitted, updates fee schedules on January 1 across all payers, and monitors payer-specific policy differences. That preparation is the difference between absorbing a revenue cut and offsetting it through billing accuracy.
Next Steps
Start by modeling the proposed 2027 fee schedule against your own procedure volume and payer mix. Focus on modifier 25 claims first, since that is where the largest per-claim impact lands for ophthalmology. If your billing process is not ready for these changes, connect with a vetted ophthalmology billing partner who can audit your workflows and prepare your practice before January 1.
The 2027 Medicare cuts are coming. Whether the final rule lands at 3% or 4%, the practices that lose the least are the ones that prepared the earliest. Ophthalmology Bill Co connects ophthalmology practices with billing companies that specialize in your codes, your modifiers, and your payer landscape. Over 200 providers have used our network to find the right billing partner. Get matched before the final rule drops.
